Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Depression, Bipolar: full-pipeline trial registry
2 of 6 indexed Depression, Bipolar trials are currently recruiting.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 2 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Depression, Bipolar: 6 US clinical trials tracked, 2 recruiting.
Depression, Bipolar is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Forest Laboratories, running 1 of these trials.
Enrollment posture brief
Registry condition depression-bipolar
OPEN 2 | RECR 33% | LATE 2 | EARLY 2 | RANK #2866 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Depression, Bipolar lists 2 open slots (33% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Depression, Bipolar on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Depression, Bipolar is recruiting below its size-band peers.
2 of 6 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Depression, Bipolar research.
Forest Laboratories accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.
-
Typical Depression, Bipolar enrolment sits around 400 participants.
Median target enrolment is 400 among the 6 trials that report a genuine target (sentinel values excluded). 2 of those (33.3%) plan for fewer than 100 participants.
-
Depression, Bipolar splits between interventional and observational designs.
4 interventional and 2 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
Dallas 2K: A Natural History Study of Depression
University of Texas Southwestern Medical Center
NCT02919280
Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality
The University of Texas Health Science Center, Houston
NCT06706232
Safety, Tolerability, and Efficacy of Cariprazine in Participants With Bipolar Depression
Forest Laboratories
NCT01396447
Phase III/Seroquel SR Bipolar Depression Monotherapy - US
AstraZeneca
NCT00422214
Functional and Neurochemical Brain Changes Bipolar Depression
University of Cincinnati
NCT00608296
Depakote ER in Bipolar Depression
Stanford University
NCT00186186
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Depression, Bipolar records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Depression, Bipolar trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Depression, Bipolar page
6 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Depression, Bipolar trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Forest Laboratories sponsors the most Depression, Bipolar trials on record, review their full trial history before evaluating a specific study. See Forest Laboratories's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Depression, Bipolar condition card totals 6 registered trials; most-linked intervention Quetiapine fumarate (Seroquel) SR; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.